Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04482400 · ClinicalTrials.gov registry record · NA

Technology Interventions to Improve Outcomes After Knee Replacement

A NA study of Knee Arthroplasty, sponsored by University of South Carolina.

Completed
Registry status
NA
Development phase
83
Enrollment target
1
Study location

NCT04482400: Completed NA study of Knee Arthroplasty, sponsored by University of South Carolina.

NCT04482400 is a NA study of Knee Arthroplasty that has completed, run by University of South Carolina. The registered enrollment target is 83 participants, below the 720-participant average among 5 other Knee Arthroplasty trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04482400, a NA study of Knee Arthroplasty, has completed, sponsored by University of South Carolina.

COMPLETED
Registry status
NA
Development phase
83 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the effects of two technology interventions on health outcomes (e.g., physical activity, sedentary behavior, physical function, pain) after knee replacement at 2 and 5 months .

Primary Outcome

sedentary behavior (\<100 counts/minute) measured with Actigraph accelerometers between baseline and 3 months

Conditions Studied

Interventions

  • BEHAVIORAL NEAT!2
  • BEHAVIORAL MyKneeGuide

Study Locations (1)

South Carolina

  • University of South Carolina - Columbia

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2020-08-01
Est. Completion 2024-10-25
Phase NA
University of South Carolina

157 total trials

What the finished NCT04482400 record still lists

NCT04482400 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 720-participant average among 5 other Knee Arthroplasty trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Knee Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which NEAT!2 is the first listed.

NCT04482400 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT04482400 about?

NCT04482400 is a clinical study titled "Technology Interventions to Improve Outcomes After Knee Replacement". The purpose of this study is to examine the effects of two technology interventions on health outcomes (e.g., physical activity, sedentary behavior, physical function, pain) after knee replacement at 2 and 5 months .

What is the current status of trial NCT04482400?

This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2020-08-01. Estimated completion is 2024-10-25.

What conditions does trial NCT04482400 study?

This clinical trial studies the following conditions: Knee Arthroplasty.

What interventions are being tested in trial NCT04482400?

The interventions under investigation include: NEAT!2 (BEHAVIORAL), MyKneeGuide (BEHAVIORAL).

Who is sponsoring clinical trial NCT04482400?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04482400 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02974647 · 83 participants · Phase 2

    Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

  • NCT03919292 · 83 participants · Phase 1

    Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

  • NCT04626674 · 83 participants · Phase 1

    A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

  • NCT05277168 · 83 participants · Phase 1

    A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04482400, the US trial registry maintained by the National Library of Medicine. NCT04482400 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.